Albert Einstein College of Medicine Wins New NIH Funding to Support Diabetes Research

0

The Albert Einstein College of Medicine received a five-year, $ 4 million grant from the National Institutes of Health (NIH) to support the New York Regional Center for Diabetes Translation Research (NY-CDTR). One of seven such centers in the country and the only one in the northeast, the NY-CDTR promotes collaboration and research on effective strategies to improve diabetes prevention, care and self-management, by emphasizing health equity.

Our center is uniquely positioned, both geographically and because of our expertise, to support researchers conducting research aimed at helping those who bear the greatest burden of diabetes in the United States – people of color and people with low socio-economic status. -economic status. We will prioritize studies aimed at reducing health inequalities and developing interventions that can be implemented in real conditions and in various health care and community settings. “

Jeffrey Gonzalez, Ph.D., Principal Investigator on the Grant and Director of the NY-CDTR

Dr Gonzalez is also Professor of Medicine and Epidemiology and Population Health at Einstein, Psychologist at Montefiore Health System and Professor of Psychology at Ferkauf Graduate School of Psychology at Yeshiva University.

Members of certain ethnic and racial groups, including Latinos / Hispanics, African Americans, and Asian Americans, face a higher risk of developing diabetes than non-Hispanic white adults. They are also at increased risk for complications from diabetes, such as lower limb amputations, vision loss, and kidney failure. In addition, diabetes is 70% more common in poorer neighborhoods than in wealthier neighborhoods.

Advancing innovation in diabetes research

The new funding will support many aspects of the centre’s operations, including its research hubs, who have been reconfigured to reflect recent advances in the field as well as Einstein’s strengths. The newly reconfigured behavior science and technology core, led by Dr. Gonzalez, now integrates telehealth, smartphone apps, continuous blood glucose monitoring devices and other technologies to manage diabetes.

NY-CDTR has two cores which are unique among the seven nationally funded centers. The Latino Network for the Translational Diabetes Research Core, led by Linda Gallo, Ph.D., at San Diego State University, builds on the Hispanic Community Health / Study of Latinos (HCHS / SOL), an ongoing study of more than 16,000 adults at four US sites, including Einstein and San Diego State. This core provides guidance to investigators on tailoring research and interventions for Latinx individuals, as well as accessing HCHS / SOL data. The Core Life Course Methodology, led by NY-CDTR Associate Director Carmen Isasi, MD, Ph.D., Associate Professor of Epidemiology and Population Health and Pediatrics at Einstein, helps researchers understand how the physical and behavioral processes that influence diabetes risk and outcomes; everything from lifestyle choices to metabolism rates; differ over the course of life and how to incorporate this information into their studies.

The Core of Population Health and Health Systems, led by NY-CDTR Associate Director Earle Chambers, Ph.D., MPH, Associate Professor of Family and Social Medicine and Epidemiology and Population Health, and Research Director in the Department of Family and Social Medicine at Einstein and Montefiore, offers expertise in community engagement as well as in health systems and other ‘big data’ research. Dr Chambers is also Director of the Center’s Enrichment Program for External and Internal Seminars, Podcasts, and Faculty / Trainee Lectures.

With the new grant and additional funding from the College of Medicine, the NY-CDTR is driving innovation through pilot and feasibility study grants for early-career researchers and those new to translational research on the diabetes. The program is led by Einstein’s Judith Wylie-Rosett, Ed.D., Professor of Epidemiology and Population Health and Medicine, and the Atran Foundation Chair in Social Medicine and Elizabeth Walker, Ph.D., RN, emeritus professor of medicine and epidemiology and population health.

Building on strengths

The center will expand its current focus on health equity and the social determinants of health through its hubs and new initiatives. Researchers are leading national efforts to address the diabetes health disparities faced by Latinx people by connecting researchers with this underserved population. Center leaders are also increasing community partnerships to guide research efforts and collaboration with other New York City institutions.

“Drs. Walker and Wylie-Rosett have been leaders in research into the prevention and control of diabetes for largely disenfranchised groups for decades,” said Dr Gonzalez. “Our pilot and feasibility program has had a great impact under their leadership, and both have been excellent mentors to many early career researchers at Einstein, including me, Carmen and Earle. We have been extremely fortunate to having them as leaders, not just at NY-CDTR but in the field in general. Our growth and success is a testament to their vision. “

NY-CDTR received its initial funding in 2016 under the leadership of Drs. Walker and Wylie-Rosett. Since then, the center has grown from an initial 77 members to 95, representing 37 institutions in the New York City area and across the country. In the first four years of funding, members published 463 research studies related to the centre’s mission, 310 of which were directly supported by the center.

Source:

Albert Einstein Faculty of Medicine

Share.

About Author

Comments are closed.